GliaCure, Inc. logo

GliaCure, Inc.

GliaCure is a privately held, virtual drug discovery company, developing novel therapeutics aimed at treating neurological and neuro psychiatric disorders of the brain.

GliaCure was founded in 2011 and is based on discoveries by its scientific founder, Philip Haydon, of Tufts University and has an exclusive license for GC021109 and its related technologies from Tufts University.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://gliacure.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
234 Causeway St, #809, Boston, MA 02114-2126
Boston
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/gliacure-inc” connections=”true” suffix=””]

The company has raised approx. $8.5 Mn to date from private investors and in 2015, has received a $1 Mn award from the Alzheimers Drug Discovery Foundation (ADDF).